Tobi Nebulizer Solution
Healthcare providers may prescribe Tobi® (tobramycin inhalation solution) to treat a certain bacterial infection in people who have cystic fibrosis. Specifically, this prescription antibiotic is approved to treat infections caused by the bacterium Pseudomonas aeruginosa. This medicine is approved for use in adults and children as young as six years old.
Tobi inhalation solution is designed to be used with a nebulizer and an air compressor. The medicine forms a mist that is inhaled. There is only one standard dose of this medication -- one ampule (300 mg per 5 mL) of solution inhaled twice daily, with about 12 hours between doses. This dosing schedule is continued for 28 days, followed by a 28-day break from using the medicine before resuming treatment.
Although most people who use this medicine tolerate it fairly well, side effects are possible. Some of the potential side effects include a sore throat, runny nose, and a worsening cough. Fortunately, most reactions to the drug tend to be mild and easy to treat.
(Click Tobi for more information on this nebulizer solution, including how it works, dosing instructions, and general safety precautions.)